Company intelligence / Profile preview

SNP Therapeutics

Kannapolis, North Carolina, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

SNP Therapeutics commercializes gene-guided diagnostic tests, notably the Genate Test for prenatal nutrition, with supporting evidence from human clinical genetics to personalize nutritional therapy for metabolic disorders. Detailed clinical study results are not published, but academic legacy and product deployment support efficacy claims.

Therapeutic areas: Men's HealthWomen's HealthMetabolic DisordersGastroenterology
Modalities: Device
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on SNP Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SNP Therapeutics.

Explore the full profile